Selected research
Industry Research
Multispectral Imaging for Skin Disease Industry Research Report 2026
Market perspective
The global Multispectral Imaging for Skin Disease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Multispectral Imaging for Skin Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Multispectral Imaging for Skin Disease market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Multispectral Imaging for Skin Disease market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Multispectral Imaging for Skin Disease include DermLite, ViseoMed, Optovue, Navitar, E-con Systems, Caliber, Emage Medical LLC, Courage + Khazaka Electronic and Longport Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Multispectral Imaging for Skin Disease market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Multispectral Imaging for Skin Disease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Multispectral Imaging for Skin Disease Market by Company
DermLite
ViseoMed
Optovue
Navitar
E-con Systems
Caliber
Emage Medical LLC
Courage + Khazaka Electronic
Longport Inc.
Cortex Technology
Atys Medical
Multispectral Imaging for Skin Disease Segment by Type
Digital Photographic Imaging
Dermoscopy
Others
Multispectral Imaging for Skin Disease Segment by Application
Pigmented Lesions
Psoriasis
Skin Cancer
Plastic and Reconstructive Surgery
Other
Multispectral Imaging for Skin Disease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multispectral Imaging for Skin Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multispectral Imaging for Skin Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multispectral Imaging for Skin Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Multispectral Imaging for Skin Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Digital Photographic Imaging
- Dermoscopy
- Others
Applications
- Pigmented Lesions
- Psoriasis
- Skin Cancer
- Plastic and Reconstructive Surgery
- Other
Companies covered
- DermLite
- ViseoMed
- Optovue
- Navitar
- E-con Systems
- Caliber
- Emage Medical LLC
- Courage + Khazaka Electronic
- Longport Inc.
- Cortex Technology
- Atys Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Multispectral Imaging for Skin Disease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Digital Photographic Imaging
- 2.2.3 Dermoscopy
- 2.2.4 Others
- 2.3 Multispectral Imaging for Skin Disease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pigmented Lesions
- 2.3.3 Psoriasis
- 2.3.4 Skin Cancer
- 2.3.5 Plastic and Reconstructive Surgery
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Multispectral Imaging for Skin Disease Breakdown Data by Type
- 3.1 Global Multispectral Imaging for Skin Disease Historic Market Size by Type (2021-2026)
- 3.2 Global Multispectral Imaging for Skin Disease Forecasted Market Size by Type (2027-2032)
4 Multispectral Imaging for Skin Disease Breakdown Data by Application
- 4.1 Global Multispectral Imaging for Skin Disease Historic Market Size by Application (2021-2026)
- 4.2 Global Multispectral Imaging for Skin Disease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Multispectral Imaging for Skin Disease Market Perspective (2021-2032)
- 5.2 Global Multispectral Imaging for Skin Disease Growth Trends by Region
- 5.2.1 Global Multispectral Imaging for Skin Disease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Multispectral Imaging for Skin Disease Historic Market Size by Region (2021-2026)
- 5.2.3 Multispectral Imaging for Skin Disease Forecasted Market Size by Region (2027-2032)
- 5.3 Multispectral Imaging for Skin Disease Market Dynamics
- 5.3.1 Multispectral Imaging for Skin Disease Industry Trends
- 5.3.2 Multispectral Imaging for Skin Disease Market Drivers
- 5.3.3 Multispectral Imaging for Skin Disease Market Challenges
- 5.3.4 Multispectral Imaging for Skin Disease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Multispectral Imaging for Skin Disease Players by Revenue
- 6.1.1 Global Top Multispectral Imaging for Skin Disease Players by Revenue (2021-2026)
- 6.1.2 Global Multispectral Imaging for Skin Disease Revenue Market Share by Players (2021-2026)
- 6.2 Global Multispectral Imaging for Skin Disease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Multispectral Imaging for Skin Disease Head Office and Area Served
- 6.4 Global Multispectral Imaging for Skin Disease Players, Product Type & Application
- 6.5 Global Multispectral Imaging for Skin Disease Manufacturers Established Date
- 6.6 Global Multispectral Imaging for Skin Disease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Multispectral Imaging for Skin Disease Market Size (2021-2032)
- 7.2 North America Multispectral Imaging for Skin Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
- 7.4 North America Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Multispectral Imaging for Skin Disease Market Size (2021-2032)
- 8.2 Europe Multispectral Imaging for Skin Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
- 8.4 Europe Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Multispectral Imaging for Skin Disease Market Size (2021-2032)
- 9.2 Asia-Pacific Multispectral Imaging for Skin Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Multispectral Imaging for Skin Disease Market Size (2021-2032)
- 10.2 South America Multispectral Imaging for Skin Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
- 10.4 South America Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Multispectral Imaging for Skin Disease Market Size (2021-2032)
- 11.2 Middle East & Africa Multispectral Imaging for Skin Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 DermLite
- 12.1.1 DermLite Company Information
- 12.1.2 DermLite Business Overview
- 12.1.3 DermLite Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.1.4 DermLite Multispectral Imaging for Skin Disease Product Portfolio
- 12.1.5 DermLite Recent Developments
- 12.2 ViseoMed
- 12.2.1 ViseoMed Company Information
- 12.2.2 ViseoMed Business Overview
- 12.2.3 ViseoMed Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.2.4 ViseoMed Multispectral Imaging for Skin Disease Product Portfolio
- 12.2.5 ViseoMed Recent Developments
- 12.3 Optovue
- 12.3.1 Optovue Company Information
- 12.3.2 Optovue Business Overview
- 12.3.3 Optovue Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.3.4 Optovue Multispectral Imaging for Skin Disease Product Portfolio
- 12.3.5 Optovue Recent Developments
- 12.4 Navitar
- 12.4.1 Navitar Company Information
- 12.4.2 Navitar Business Overview
- 12.4.3 Navitar Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.4.4 Navitar Multispectral Imaging for Skin Disease Product Portfolio
- 12.4.5 Navitar Recent Developments
- 12.5 E-con Systems
- 12.5.1 E-con Systems Company Information
- 12.5.2 E-con Systems Business Overview
- 12.5.3 E-con Systems Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.5.4 E-con Systems Multispectral Imaging for Skin Disease Product Portfolio
- 12.5.5 E-con Systems Recent Developments
- 12.6 Caliber
- 12.6.1 Caliber Company Information
- 12.6.2 Caliber Business Overview
- 12.6.3 Caliber Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.6.4 Caliber Multispectral Imaging for Skin Disease Product Portfolio
- 12.6.5 Caliber Recent Developments
- 12.7 Emage Medical LLC
- 12.7.1 Emage Medical LLC Company Information
- 12.7.2 Emage Medical LLC Business Overview
- 12.7.3 Emage Medical LLC Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.7.4 Emage Medical LLC Multispectral Imaging for Skin Disease Product Portfolio
- 12.7.5 Emage Medical LLC Recent Developments
- 12.8 Courage + Khazaka Electronic
- 12.8.1 Courage + Khazaka Electronic Company Information
- 12.8.2 Courage + Khazaka Electronic Business Overview
- 12.8.3 Courage + Khazaka Electronic Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.8.4 Courage + Khazaka Electronic Multispectral Imaging for Skin Disease Product Portfolio
- 12.8.5 Courage + Khazaka Electronic Recent Developments
- 12.9 Longport Inc.
- 12.9.1 Longport Inc. Company Information
- 12.9.2 Longport Inc. Business Overview
- 12.9.3 Longport Inc. Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.9.4 Longport Inc. Multispectral Imaging for Skin Disease Product Portfolio
- 12.9.5 Longport Inc. Recent Developments
- 12.10 Cortex Technology
- 12.10.1 Cortex Technology Company Information
- 12.10.2 Cortex Technology Business Overview
- 12.10.3 Cortex Technology Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.10.4 Cortex Technology Multispectral Imaging for Skin Disease Product Portfolio
- 12.10.5 Cortex Technology Recent Developments
- 12.11 Atys Medical
- 12.11.1 Atys Medical Company Information
- 12.11.2 Atys Medical Business Overview
- 12.11.3 Atys Medical Revenue in Multispectral Imaging for Skin Disease Business (2021-2026)
- 12.11.4 Atys Medical Multispectral Imaging for Skin Disease Product Portfolio
- 12.11.5 Atys Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst